Zai Lab
ZLAB
21.03
-0.89
-4.06%
Zai Lab
US · ZLAB
#2554 by market cap
Listed 2017
21.03
-0.89
-4.06%
Periodic snapshot; not a real-time feed.
· 2026-11-20 19:30
Recent news
-
Rating change
Cantor Fitzgerald Maintains Zai Lab(ZLAB.US) With Buy Rating, Cuts Target Price to $37Market Newswire · 2026/2/27
-
Rating change
Citi Maintains Zai Lab(ZLAB.US) With Buy Rating, Maintains Target Price $53Market Newswire · 2026/2/23
-
Citi Maintains Zai Lab(ZLAB.US) With Buy Rating, Maintains Target Price $45Market Newswire · 2026/10/19
-
U.S. Stock Market Movements | Zai Lab (ZLAB.US) rises over 2% on positive Phase I data for investigational ADC ZolbetuximabZhitong Finance · 2026/10/23
-
Rating change
Citi Maintains Zai Lab(ZLAB.US) With Buy Rating, Raises Target Price to $45Market Newswire · 2026/8/7
-
Rating change
J.P. Morgan Maintains Zai Lab(ZLAB.US) With Buy Rating, Announces Target Price $27Market Newswire · 2026/5/23
-
Rating change
Citi Maintains Zai Lab(ZLAB.US) With Buy Rating, Cuts Target Price to $47Market Newswire · 2026/2/27
-
Rating change
J.P. Morgan Maintains Zai Lab(ZLAB.US) With Buy RatingMarket Newswire · 2026/4/21
-
Rating change
Citi Maintains Zai Lab(ZLAB.US) With Buy Rating, Cuts Target Price to $44Market Newswire · 2026/5/8
-
Rating change
J.P. Morgan Keeps Their Buy Rating on Zai Lab (ZLAB)TipRanks · 2026/9/2
-
J.P. Morgan Maintains Zai Lab(ZLAB.US) With Buy Rating, Maintains Target Price $36Market Newswire · 2026/9/2
-
Rating change
Citi Maintains Zai Lab(ZLAB.US) With Buy Rating, Maintains Target Price $47Market Newswire · 2026/3/10
-
Rating change
Analysts Offer Insights on Healthcare Companies: Zai Lab (ZLAB), Maze Therapeutics, Inc. (MAZE) and Compass Therapeutics (CMPX)TipRanks · 2026/3/26
-
Rating change
J.P. Morgan Maintains Zai Lab(ZLAB.US) With Buy Rating, Maintains Target Price $32Market Newswire · 2026/3/26
-
Rating change
BofA Securities Maintains Zai Lab(ZLAB.US) With Hold Rating, Cuts Target Price to $21.8Market Newswire · 2026/2/27
-
Rating change
J.P. Morgan Maintains Zai Lab(ZLAB.US) With Buy Rating, Raises Target Price to $36Market Newswire · 2026/8/27
-
Cantor Fitzgerald Maintains Zai Lab(ZLAB.US) With Buy Rating, Maintains Target Price $37Market Newswire · 2026/10/26
-
Rating change
J.P. Morgan Maintains Zai Lab(ZLAB.US) With Buy Rating, Cuts Target Price to $32Market Newswire · 2026/3/18
-
Rating change
Citi Maintains Zai Lab(ZLAB.US) With Buy Rating, Cuts Target Price to $53Market Newswire · 2026/2/20
-
Earnings Flash (ZLAB) Zai Lab Limited Reports Q3 Loss of $0.41 per ADS, Vs. FactSet Est of $-0.58MT Newswires · 2026/11/5
-
Rating change
J.P. Morgan Maintains Zai Lab(ZLAB.US) With Buy Rating, Announces Target Price $39Market Newswire · 2026/2/5
-
U.S. Stocks Move | Zai Lab (ZLAB.US) Surges Over 12% as Q2 Product Revenue Rises 11% SequentiallyZhitong Finance · 2026/8/6
-
US Stock Movement | Shares Surge for Two Consecutive Days! Zai Lab (ZLAB.US) Rises Over 10%Zhitong Finance · 2026/8/7
-
Rating change
Cantor Fitzgerald Maintains Zai Lab(ZLAB.US) With Buy Rating, Maintains Target Price $37Market Newswire · 2026/8/7
Headlines are aggregated automatically and are not independently verified or edited by our team.
Quote time 2026-11-20 19:30:05 · For reference only, not investment advice and not tailored to your situation.
Zai Lab discussion 0 comments